Inogen Inc company insiders have only been selling lately: one insider reduced their stakes by about $143,000 of stock over 12 months, with no open-market purchases.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
2 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters. Big money check: 129 institutions held INGN as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Yi Boyer Jennifer M | Executive Officer | Sell | 10,938 | $6.60 | $72K | SEC |
| Jun 2, 2026 | Yi Boyer Jennifer M | Executive Officer | Sell | 10,770 | $6.53 | $70K | SEC |
| Mar 4, 2025 | Bourque Michael J. | CFO | Buy | 3,000 | $8.32 | $25K | SEC |
| Mar 4, 2025 | Smith Kevin Raymond Merrill | CEO | Buy | 11,709 | $8.56 | $100K | SEC |
| May 14, 2024 | Somer Jason | Executive Officer | Sell | 10,000 | $8.56 | $86K | SEC |
In the last 12 months Inogen Inc insiders made open-market purchases worth about $0 and sales worth about $143,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in INGN was filed on 2026-07-06.
129 investment managers reported holding INGN in SEC Form 13F filings for Q2 2026.
No congressional trades in INGN were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).